Eclipse led a $125m Series B round in ForSight Robotics.

Eclipse, a venture firm, led a $125m Series B round in ForSight Robotics, an ophthalmic robotic surgery company. “We see ophthalmology as the next frontier in the robotics revolution – much like general surgery was before the rise of Intuitive Surgical. With a comparable market size and an urgent global need, our opportunity ahead is immense. Through our latest funding round, we will bring the same level of transformative impact to eye surgery, with technology designed specifically for its unique precision and complexity," Dr. Joseph Nathan, ForSight Robotics Co-Founder, President, and CEO.